Novartis

News

Novartis succeeds where Roche failed with PI3K breast cancer...

Novartis published trial results showing its drug succeeded in tackling difficult to treat breast cancer with PIK3CA mutation, after other pharma giants including Roche failed and abandoned

News

Novartis appoints new ethics chief after Trump lawyer paymen...

Novartis is aiming to draw a line under a scandal involving payments to Donald Trump's former lawyer with a new ethics chief - Siemens' former compliance head Klaus Moosmayer.

News

Breakthrough designation for Roche/Novartis' Xolair in food ...

Xolair, a drug developed 15 years ago by Roche and Novartis, received a breakthrough designation from the US regulator in a new food allergy indication.

News

Concerns over Teva migraine drug because of manufacturing is...

There are concerns that launch of Teva’s migraine drug may be delayed because of issues uncovered by the FDA at a manufacturing plant run by South Korea’s Celltrion.

News

Breakthrough migraine prevention treatment approved in Europ...

Novartis’ Aimovig (erenumab) has been approved by the European Medicines Agency (EMA) making it first self-administered, monthly migraine prevention jab available for adult patients in Euro

News

Novartis freezes drug prices in a nod to Trump

Novartis has announced it would not raise drug prices in the US this year, while Merck & Co announced huge cuts in the price of its hepatitis drug following pressure from president Trum

Novartis succeeds where Roche failed with PI3K breast cancer...

Novartis appoints new ethics chief after Trump lawyer paymen...

Breakthrough designation for Roche/Novartis' Xolair in food ...

Concerns over Teva migraine drug because of manufacturing is...

Breakthrough migraine prevention treatment approved in Europ...

Novartis freezes drug prices in a nod to Trump

Treating the chronic diseases GLP-1s miss, with Laurent Auda...

How to meet your physicians where they are online

Novartis

Editor's Picks